STAT3 and non-small cell lung carcinoma: Dihydroartemisinin significantly reduced the expression of receptor tyrosine kinase-like orphan receptor 1 (ROR1), the phosphorylation level of STAT3, and the expression of its downstream target c-Myc in two human NSCLC cell lines (PC9 and NCI-H1975).